MDR Stock Overview
Provides pharmacy-driven patient engagement solutions in Australia, New Zealand, the United States, and the United Kingdom. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for MDR from our risk checks.
MedAdvisor Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.29 |
| 52 Week High | AU$0.59 |
| 52 Week Low | AU$0.17 |
| Beta | 0.83 |
| 11 Month Change | -22.37% |
| 3 Month Change | -34.44% |
| 1 Year Change | 78.79% |
| 33 Year Change | -23.38% |
| 5 Year Change | -17.37% |
| Change since IPO | -17.37% |
Recent News & Updates
Recent updates
Shareholder Returns
| MDR | AU Healthcare Services | AU Market | |
|---|---|---|---|
| 7D | 11.3% | 2.7% | -0.07% |
| 1Y | 78.8% | 121.0% | 16.9% |
Return vs Industry: MDR underperformed the Australian Healthcare Services industry which returned 121% over the past year.
Return vs Market: MDR exceeded the Australian Market which returned 16.9% over the past year.
Price Volatility
| MDR volatility | |
|---|---|
| MDR Average Weekly Movement | 12.2% |
| Healthcare Services Industry Average Movement | 8.2% |
| Market Average Movement | 8.5% |
| 10% most volatile stocks in AU Market | 17.0% |
| 10% least volatile stocks in AU Market | 3.4% |
Stable Share Price: MDR has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: MDR's weekly volatility (12%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | n/a | Rick Ratliff | www.medadvisorsolutions.com |
MedAdvisor Limited, together with its subsidiaries, provides pharmacy-driven patient engagement solutions in Australia, New Zealand, the United States, and the United Kingdom. The company provides MedAdvisor, a vaccination and clinical workflow recording solution; and THRiV, an omni-channel intelligent patient management platform, that enables individualized patient engagement through the community pharmacy. MedAdvisor Limited was incorporated in 2010 and is based in Melbourne, Australia.
MedAdvisor Limited Fundamentals Summary
| MDR fundamental statistics | |
|---|---|
| Market cap | AU$162.64m |
| Earnings (TTM) | AU$792.13k |
| Revenue (TTM) | AU$122.11m |
205.3x
P/E Ratio1.3x
P/S RatioIs MDR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MDR income statement (TTM) | |
|---|---|
| Revenue | AU$122.11m |
| Cost of Revenue | AU$94.19m |
| Gross Profit | AU$27.92m |
| Other Expenses | AU$27.13m |
| Earnings | AU$792.13k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0014 |
| Gross Margin | 22.86% |
| Net Profit Margin | 0.65% |
| Debt/Equity Ratio | 23.9% |
How did MDR perform over the long term?
See historical performance and comparison